glp-1 launch youtheory® & Weight Loss Expert Doctor-Formulated Support – Youtheory New Medicare GLP-1 Bridge Program
Description
Most side effects occur due to unbalanced consumption and overdose
With regards to diabetes, it is now well established that chronic administration of GLP-1R mimetics not only enhances insulin secretion but also positively influences overall islet function, restoring normal morphology in even severe models of diabetes (105)
They persist for years after weight loss
FDA removed tirzepatide from the shortage list in October 2024 and semaglutide in February 2025
